In the published article, there was an error in the Funding statement. The funding statement for the National Natural Science Foundation of China was displayed as “(8197152432 and 82104809).” The correct Funding statement appears below.
“Funding
This study was supported by the National Natural Science Foundation of China (81973833 and 82104809), and the Hunan University of Chinese Medicine Graduate student innovation topics (2020CX18).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
acute-on-chronic liver failure, Wenyang Jiedu Huayu formula, network pharmacology, atractylenolide I, rat hepatocytes, ACLF rat model
Citation
Tang D, Wang R-Y, Sun K-W, Wu Y, Ding L and Mo Y (2022) Corrigendum: Network pharmacology-based prediction of active compounds in Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support in vitro and in vivo. Front. Pharmacol. 13:1105804. doi: 10.3389/fphar.2022.1105804
Received
23 November 2022
Accepted
24 November 2022
Published
01 December 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Tang, Wang, Sun, Wu, Ding and Mo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ke-Wei Sun, keweisun550@163.com
† These authors have contributed equally to this work
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.